Discontinued — last reported Q2 '24
MetLife Credit Risk Derivatives, at Fair Value, Net increased by 28.9% to $196.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.5%, from $201.00M to $196.00M. Over 5 years (FY 2020 to FY 2025), Credit Risk Derivatives, at Fair Value, Net shows a downward trend with a -5.0% CAGR.
other_credit_risk_derivatives_at_fair_value_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $186.00M | $175.00M | $165.00M | $129.00M | -$49.00M | -$11.00M | $105.00M | $106.00M | $183.00M | $146.00M | $228.00M | $264.00M | $242.00M | $265.00M | $196.00M | $201.00M | $233.00M | $232.00M | $152.00M | $196.00M |
| QoQ Change | — | -5.9% | -5.7% | -21.8% | -138.0% | +77.6% | >999% | +1.0% | +72.6% | -20.2% | +56.2% | +15.8% | -8.3% | +9.5% | -26.0% | +2.6% | +15.9% | -0.4% | -34.5% | +28.9% |
| YoY Change | — | — | — | — | -126.3% | -106.3% | -36.4% | -17.8% | +473.5% | >999% | +117.1% | +149.1% | +32.2% | +81.5% | -14.0% | -23.9% | -3.7% | -12.5% | -22.4% | -2.5% |